Publication number: 20260285888
Abstract: Provided is a novel therapeutic agent for central nervous system diseases. Provided is a compound represented by formula (I) or a salt thereof: wherein R1 and R2 each independently represent —O?, —OR4, or —NR4NaR4Nb; R3 represents hydrogen or alkyl; R4, R4Na, and R4Nb each independently represent hydrogen, or alkyl, alkenyl, alkadienyl, or alkynyl each optionally having 1 to 3 substituents, wherein alkyl represented by R4, R4Na, or R4Nb may have a structure in which one or more methylene groups (—CH2—) are replaced with —O—, —S—, —CO—, —NH—, —SiRsiaRsib—, or —(CO)O—; if R1 and R2 both represent —OR4, R1 and R2 may be identical or different; and if R1 and R2 both represent —NR4NaR4Nb, R1 and R2 may be identical or different.
Type:
Application
Filed:
May 2, 2024
Publication date:
September 24, 2026
Applicant:
OTSUKA PHARMACEUTICAL CO., LTD.
Inventors:
Nobuaki ITO, Minoru OKADA, Yohei YUKI, Toshio SHINNOHARA, Masashi HAYASHI, Tetsuya SATO, Takuya MINOWA, Daiki KANEKO, Nobutomo SAKO, Shinya OKAWA, Akie OKADA, Naoji KIMURA, Atsushi HOSOMI, Takakuni MATSUDA, Toshihisa KOGA, Reo KAWATA, Noriaki YODA